TherapeuticsMD Ownership | Who Owns TherapeuticsMD?

Overview Forecast RevenueFinancials Chart

TherapeuticsMD Ownership Summary

TherapeuticsMD is owned by 20.93% institutional investors, 1.55% insiders, and 77.52% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.30% of TXMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TherapeuticsMD	20.93%	1.55%	77.52%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.82%	11.62%	67.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rubric capital management lp	1.19M	10.30%	$1.94M
Clearline capital lp	635.22K	5.49%	$682.86K
Vanguard group	397.06K	3.43%	$647.20K
Tejara capital	350.85K	3.03%	$571.89K
Adar1 capital management	209.21K	1.81%	$224.90K
Morgan stanley	129.22K	1.12%	$210.62K
Blackrock	125.15K	1.09%	$201.50K
Blackrock funding, inc. /de	116.13K	1.00%	$189.29K
Geode capital management	106.10K	0.92%	$172.98K
Renaissance	96.50K	0.83%	$157.29K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tejara capital	350.85K	0.13%	$571.89K
Clearline capital lp	635.22K	0.03%	$682.86K
Rubric capital management lp	1.19M	0.02%	$1.94M
Adar1 capital management	209.21K	0.02%	$224.90K
Two sigma securities	11.97K	0.00%	$12.87K
Bridgeway capital management	34.00K	0.00%	$36.04K
J. goldman & co lp	13.56K	0.00%	$14.58K
Renaissance	96.50K	0.00%	$157.29K
Tower research capital llc (trc)	2.73K	0.00%	$2.94K
Guardian wealth management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	96.50K	0.00%	61.00K
Vanguard group	397.06K	-	20.23K
Tejara capital	350.85K	0.13%	6.65K
Group one trading	1.60K	-	1.60K
Two sigma securities	11.97K	0.00%	1.53K

Top Sellers

Holder	Shares	% Assets	Change
Clear harbor asset management	-	-	-25.81K
Prosperity consulting group	-	-	-24.50K
Ameriprise financial	-	-	-22.47K
Gabelli funds	-	-	-12.00K
Blackrock	125.15K	-	-10.63K

New Positions

Holder	Shares	% Assets	Change	Value
Group one trading	1.60K	-	1.60K	$2.60K
Wealth watch advisors	22.00	-	22.00	$24.00
Cibc private wealth group	20.00	-	20.00	$33.00

Sold Out

Holder	Change
Sterling capital management	-1.00
Aspire private capital	-1.00
Guardian wealth management	-2.00
Northwestern mutual wealth management	-2.00
Qube research	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	31	-27.91%	2,422,829	-26.67%	20	2.57%	8	-	2	-80.00%
Sep 30, 2025	39	-4.88%	3,303,751	1.48%	28	3.61%	6	-45.45%	10	25.00%
Jun 30, 2025	40	-2.44%	3,254,871	-2.65%	28	3.36%	10	-9.09%	9	12.50%
Mar 31, 2025	40	2.56%	3,343,569	-5.25%	28	3.09%	11	-	8	60.00%
Dec 31, 2024	24	-31.43%	1,302,899	-61.44%	11	1.32%	8	-	3	-25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	249.66K	2.16%	-
Vanguard Total Stock Mkt Idx Inv	244.32K	2.11%	-
Vanguard Institutional Extnd Mkt Idx Tr	90.88K	0.79%	6.90K
Fidelity Extended Market Index	67.74K	0.59%	5.14K
Blackrock Extended Mkt Fund CF	18.69K	0.16%	18.69K
Bridgeway Ultra-Small Company Market	17.00K	0.15%	-17.00K
BlackRock Extended Equity Market K	16.29K	0.14%	-7.00
Extended Equity Market Fund K	16.03K	0.14%	10.00
Fidelity Series Total Market Index	15.32K	0.13%	-
Fidelity Total Market Index	14.84K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 23, 2025	Thompson Tommy G	-	Buy	$14.03K
Apr 14, 2025	Thompson Tommy G	-	Buy	$325.59
Apr 14, 2025	Walker Marlan D	Chief Executive Officer	Buy	$489.27
Apr 09, 2025	Walker Marlan D	Chief Executive Officer	Buy	$993.66
Apr 10, 2025	Walker Marlan D	Chief Executive Officer	Buy	$1.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q2	4	-
2025 Q1	-	-
2024 Q3	2	-
2023 Q4	-	2

TXMD Ownership FAQ

Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 20.93%, followed by 1.55% insiders and 77.52% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which TherapeuticsMD exceeds.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.30%), Clearline capital lp (635.22K shares, 5.49%), and Vanguard group (397.06K shares, 3.43%). Together, they hold 19.22% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 350.85K TherapeuticsMD shares, valued at 571.89K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools